π’
|
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.
11 auth.
Atul Sharma,
A. Dwary,
B. Mohanti,
S. Deo,
S. Pal,
V. Sreenivas,
...
V. Raina,
N. Shukla,
S. Thulkar,
P. Garg,
S. Chaudhary
|
8 |
2010 |
8 π’
|
π¬
|
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
Atul Sharma,
G. Rath,
S. Chaudhary,
A. Thakar,
B. Mohanti,
S. Bahadur
|
6 |
2012 |
6 π¬
|
π
|
Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation
9 auth.
Atul Sharma,
T. Tilak,
S. Bakhshi,
V. Raina,
L. Kumar,
S. Chaudhary,
...
R. Sahoo,
Ritu Gupta,
S. Thulkar
|
5 |
2016 |
5 π
|
π
|
Bintrafusp alfa versus pembrolizumab in patients with treatment-naive, PD-L1-high advanced non-small cell lung cancer: a randomized, open-label, phase 3 trial.
25 auth.
B. Cho,
J. Lee,
Yi-long Wu,
I. ΓiΓ§in,
M. C. Dols,
M. Ahn,
K. Cuppens,
R. Veillon,
E. Nadal,
Josiane M Dias,
C. Martin,
M. Reck,
E. Garon,
E. Felip,
L. Paz-Ares,
...
F. Mornex,
E. Vokes,
A. Adjei,
C. Robinson,
Masashi Sato,
Y. Vugmeyster,
A. Machl,
F. Audhuy,
S. Chaudhary,
F. Barlesi
|
4 |
2023 |
4 π
|
π
|
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
17 auth.
L. Goyal,
S. Chaudhary,
E. Kwak,
T. Abrams,
A. Carpenter,
B. Wolpin,
R. Wadlow,
Jill N. Allen,
R. Heist,
N. McCleary,
...
J. Chan,
W. Goessling,
D. Schrag,
K. Ng,
P. Enzinger,
D. Ryan,
Jeffrey W. Clark
|
4 |
2020 |
4 π
|
π
|
Final results of a phase III randomized controlled trial comparing modified gemcitabine + oxaliplatin (mGEMOX) to gemcitabine+ cisplatin in management of unresectable gall bladder cancer (GBC).
17 auth.
Atul Sharma,
N. Shukla,
S. Chaudhary,
R. Sahoo,
B. Mohanti,
S. Deo,
S. Pal,
S. Thulkar,
Sunil Kumar,
S. Pathy,
...
P. Sahni,
S. Vishnubhatla,
S. Bhatnagar,
N. Dash,
Rakesh Kumar,
V. Raina,
V. Iyer
|
2 |
2016 |
2 π
|
π
|
Final results of a phase II/III, randomized, double blind, placebo-controlled study to investigate the efficacy of a high potency multistrain probiotic, on chemotherapy induced diarrhea in cancer patients receiving fluropyrimidines and/or irinotecan-based therapy.
8 auth.
A. Sharma,
S. Chaudhary,
V. Raina,
N. Shukla,
V. Sreenivas,
S. Prakash,
...
P. Priyatma,
S. Bharti
|
2 |
2018 |
2 π
|
π’
|
Immunoproliferative small intestinal disease: a report of 6 cases.
7 auth.
B. Biswas,
Atul Sharma,
G. Makharia,
S. Thulkar,
S. Arava,
A. Bahl,
...
S. Chaudhary
|
2 |
2014 |
2 π’
|